Company: GRCE
Filing Date: 2025-03-10
Form Type: S-3
Source: 0001140361-25-007769
Chunk: 19

Company: Grace Therapeutics, Inc.
Filing Date: 2025-03-10
Form: S-3
Chunk 19
---
 Stockholder as a General Partner,     
 Investment Manager, or Sub-Advisor and would be considered the beneficial owner of such securities. The above shall not be deemed to be an admission by the record owners or this Selling Stockholder that they are themselves beneficial    
 owners of these securities for purposes of Section 13(d) of the Exchange Act, or any other purpose. Wilmot Harkey and Daniel Mack are managing members of Nantahala Capital Management, LLC and may be deemed to have voting and dispositive 
 power over the shares held by this Selling Stockholder. The address of Blackwell Partners LLC – Series A is c/o Blackwell Partners LLC – Series A, 280 South Mangum Street, Suite 210, Durham, NC 27701.                                     |

| (7) | The number of shares of Common Stock beneficially owned prior to this offering includes 331,376 shares of Common Stock                                                                                                                     
 underlying warrants owned by this Selling Stockholder. Under the terms of such warrants, the holder may not exercise the warrants to the extent such exercise would cause such holder, together with its affiliates, to beneficially own a 
 number of shares of Common Stock which would exceed the 4.99% Ownership Cap. Upon 61 days’ advance written notice to us, the holder of such warrants may from time to time increase or decrease the 4.99% Ownership Cap percentage up to   
 19.99%. The address of The Hewlett Fund is c/o The Hewlett Fund, 100 Merrick Road – Suite 400W, Rockville Centre, NY 11570.                                                                                                                |

| (8) | The number of shares of Common Stock beneficially owned prior to this offering includes 162,448 shares of Common Stock                                                                                                                     
 underlying warrants owned by this Selling Stockholder. Under the terms of such warrants, the holder may not exercise the warrants to the extent such exercise would cause such holder, together with its affiliates, to beneficially own a 
 number of shares of Common Stock which would exceed                                                                                                                                                                                        |

7

TABLE OF CONTENTS

the 4.99% Ownership Cap. Upon 61 days’ advance written notice to us, the holder of such warrants may from time to time increase or decrease the 4.99% Ownership Cap percentage up to 19.99%. The number of shares beneficially owned prior to this offering does not include 367,743 shares of Common Stock shares underlying such warrants as a result of the Ownership Cap and the 61 days’ advance notice